Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.
Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Trawinski J, Amann-Zalan I, Hoersch S, Katus HA. Hartmann F, et al. Among authors: hoersch s. Eur J Heart Fail. 2004 Mar 15;6(3):343-50. doi: 10.1016/j.ejheart.2004.01.009. Eur J Heart Fail. 2004. PMID: 14987586 Free article. Clinical Trial.
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD, Amann-Zalan I, Hoersch S, Katus HA. Hartmann F, et al. Among authors: hoersch s. Circulation. 2004 Sep 28;110(13):1780-6. doi: 10.1161/01.CIR.0000143059.68996.A7. Epub 2004 Sep 20. Circulation. 2004. PMID: 15381643 Clinical Trial.
Benchmarking tools for transcription factor prioritization.
Santana LS, Reyes A, Hoersch S, Ferrero E, Kolter C, Gaulis S, Steinhauser S. Santana LS, et al. Among authors: hoersch s. Comput Struct Biotechnol J. 2024 May 11;23:2190-2199. doi: 10.1016/j.csbj.2024.05.016. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38817966 Free PMC article.
Integrative Proteogenomics for Differential Expression and Splicing Variation in a DM1 Mouse Model.
Solovyeva EM, Utzinger S, Vissières A, Mitchelmore J, Ahrné E, Hermes E, Poetsch T, Ronco M, Bidinosti M, Merkl C, Serluca FC, Fessenden J, Naumann U, Voshol H, Meyer AS, Hoersch S. Solovyeva EM, et al. Among authors: hoersch s. Mol Cell Proteomics. 2024 Jan;23(1):100683. doi: 10.1016/j.mcpro.2023.100683. Epub 2023 Nov 21. Mol Cell Proteomics. 2024. PMID: 37993104 Free PMC article.
Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19.
Herr C, Mang S, Mozafari B, Guenther K, Speer T, Seibert M, Srikakulam SK, Beisswenger C, Ritzmann F, Keller A, Mueller R, Smola S, Eisinger D, Zemlin M, Danziger G, Volk T, Hoersch S, Krawczyk M, Lammert F, Adams T, Wagenpfeil G, Kindermann M, Marcu C, Ataya ZWD, Mittag M, Schwarzkopf K, Custodis F, Grandt D, Schaefer H, Eltges K, Lepper PM, Bals R; CORSAAR Study Group. Herr C, et al. Among authors: hoersch s. J Inflamm Res. 2021 Sep 15;14:4651-4667. doi: 10.2147/JIR.S320685. eCollection 2021. J Inflamm Res. 2021. PMID: 34552347 Free PMC article.
Conservative management of COVID-19 associated hypoxaemia.
Supady A, Lepper PM, Bracht H, Moerer O, Muellenbach RM, Michels G, Fiedler MO, Kalenka A, Kochanek M, Mutlak H, Danziger G, Muenz S, Lunz D, Hoersch S, Staudacher D, Wengenmayer T, Zotzmann V. Supady A, et al. Among authors: hoersch s. ERJ Open Res. 2021 Jun 21;7(2):00204-2021. doi: 10.1183/23120541.00204-2021. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 34159186 Free PMC article.
New insights into molecular changes in skeletal muscle aging and disease: Differential alternative splicing and senescence.
Solovyeva EM, Ibebunjo C, Utzinger S, Eash JK, Dunbar A, Naumann U, Zhang Y, Serluca FC, Demirci S, Oberhauser B, Black F, Rausch M, Hoersch S, Meyer AS. Solovyeva EM, et al. Among authors: hoersch s. Mech Ageing Dev. 2021 Jul;197:111510. doi: 10.1016/j.mad.2021.111510. Epub 2021 May 19. Mech Ageing Dev. 2021. PMID: 34019916 Free article.
Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE.
Perez EA, Barrios C, Eiermann W, Toi M, Im YH, Conte P, Martin M, Pienkowski T, Pivot XB, Burris HA 3rd, Petersen JA, De Haas S, Hoersch S, Patre M, Ellis PA. Perez EA, et al. Among authors: hoersch s. Cancer. 2019 Nov 15;125(22):3974-3984. doi: 10.1002/cncr.32392. Epub 2019 Jul 18. Cancer. 2019. PMID: 31318460 Free article.
40 results